Narrative review highlights the prevalence and resistance profiles of extra-otic infections by T. otitidis, suggesting increased attention in immunocompromised patients.
Turicella otitidis is a Gram-positive bacillus, commensal inhabitant of the external auditory canal. It is the causative agent of external otitis and otitis media. Extra-otic infections are rarely been identified especially in patients with comorbidities. A narrative review was performed based on a search of PubMed/Medline and Scopus databases to collect information on the epidemiologic, clinical and microbiologic data of extra-otic infections by T. otitidis . Studies published until December 2024 were screened and analyzed to extract data on pathogen characteristics, antibiotic resistance profiles, treatment and outcomes. A total of 13 studies reporting infections by T. otitidis other than otitis including an equal number of patients were eligible. The mean age of patients was 34.08 years (range, 3-75 years). A male predominance was observed (1.6:1). Four patients were immunocompromised and four underwent recent surgical procedures. The most common infection type was bacteremia (38.4%), followed by abscesses, mastoiditis, ocular infections and skin and soft tissues infections. In the majority of cases (63.6%) a single method of identification was applied, such as matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), polymerase chain reaction (PCR), Vitek 2 automated system and analytical profile index (API) Coryne. Antimicrobial resistance to erythromycin was 80%, while all isolates were susceptible to vancomycin. Vancomycin (45.5%) and cephalosporins (45.5%) were the most commonly used antimicrobials. In all cases with available data, the outcome was favorable. T. otitidis is an emerging pathogen causing extra-otic infections in humans, especially in the presence of predisposing conditions. Future studies are warranted to elucidate the microorganism's pathogenicity and the factors and mechanisms underlying its virulence.
No takes yet. Share an insight, caveat, or question.
Maraki et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: